Licensing Agreements: Maximizing Value While Mitigating Risk
A Joint Seminar Hosted by Grant Thornton LLP and Foley & Lardner LLP
16 June 2021
Licensing arrangements can enable businesses to monetize their intellectual property through very effective and efficient arrangements. However, simply entering into a licensing agreement does not guarantee that the business will maximize value. In fact, failure to adequately address certain risks can result in not only a poor financial outcome but also strained relationships with business partners and disruption to critical business operations. View this webinar to learn from legal and financial experts how you can increase the probability of maximizing value and mitigating risk in these arrangements.
Topics of discussion included:
- Drafting the agreement—lessons learned in litigation
- Reporting and monitoring mechanisms
- Managing the audit process
View the webinar recording below.
People
Related Insights
21 March 2025
IP Litigation Current
Federal Circuit Opens the Door to Additional Domestic Industry Investment: “Ordinary Importer” No Longer
In its recent decision in Lashify, Inc. v. International Trade Commission, the Federal Circuit opened the door for patent owners to include expanded categories of domestic investment to satisfy the economic prong of the domestic industry requirement under Section 337(a)(3)(B).
21 March 2025
Manufacturing Industry Advisor
Federal Court Rejects FCA’s “65%-100%” Language as Insufficient to Constitute the Necessary Quantity Term in a Requirements Contract—A Win for Suppliers
A recent federal court decision marks an important win for automotive suppliers in the ongoing debate over what constitutes a valid requirements contract under Michigan law following the Michigan Supreme Court’s decision in MSSN, Inc. v. Airboss Flexible Products Co. (2023).
27 April 2025
Events
Innovative Payment Strategies in Proton Therapy: Addressing Challenges and Driving Value
Foley partner Kinal Patel is speaking at the 2025 National Proton Conference in a panel titled “Innovative Payment Strategies in Proton Therapy: Addressing Challenges and Driving Value” on April 27.